A new clinical study by Tulane University is teaming up with Biostrap to investigate the long term cardiovascular and behavioral impacts of Covid-19.
This new observational study aims at using the wearable Biostrap for health monitoring in COVID-19 positive individuals to monitor persistent symptoms and any potential long-term complications or cardiovascular and behavioral impacts from the disease.
- Whoop becomes the first wearable to be used in a Phase-3 COVID 19 vaccine trial
- Sleep Apnea? The new Withings ScanWatch promises to deliver where it matters most
- Apple and German Heart Foundation team up around using Apple Watch for dilated cardiomyopathy
- Whoop Fitness Band exploring Tissue Oxygen saturation detection and monitoring
- Whoop working towards features to monitor IBD Flareups
How the Biostrap works
Participants will wear a Biostrap wristband device that captures high-fidelity, raw photoplethysmography (PPG) waveforms and collects important indicators of heart and mental health, including heart rate, heart rate variability, pulse points, oxygen saturation, and sleep patterns.
Biometric data will be collected and participants will be alerted if any measurements are outside their normal range.
Researchers are recruiting 100 participants who were diagnosed with COVID-19. The study’s primary outcome measures include the detection of any major cardiovascular events such as arrhythmia occurrence or recurrence, congestive heart failure, myocardial infarction, cardiomyopathy, and ischemic stroke.
Participants will also be monitored for any signs of atrial arrhythmia including atrial fibrillation, atrial flutter, and atrial tachycardia. This study is expected to run for a period of 12 months.
Biostrap’s new sleep and health tracker, Biostrap EVO is getting ready to be shipped to the general public starting this November.
The Biostrap EVO is a personal health monitor that measures, analyzes, and provides actionable insights on Sleep quality, Recovery metrics, Nocturnal biometrics, and comprehensive analysis reports.
The EVO is IP68 and has a Raw waveform Optical sensor (IR and Red). This new wearable is currently priced at $249.
Although the battery life between charges is only 2.5 days, Biostream health ad fitness tracker have been used extensively in several validation studies and has shown promising results when it comes to the accuracy of the readings and also detection of Afib (atrial fibrillation) as well as detection of obstructive hypertrophic cardiomyopathy.